Bath & Body Works reported second-quarter earnings that exceeded analyst projections, while revenue aligned with estimates. The specialty retailer posted adjusted earnings per share of $0.62, topping the $0.24 consensus forecast by $0.38. Quarterly revenue totaled $1.5 billion, matching the $1.5 billion consensus estimate.
The company also provided fiscal 2027 earnings guidance, projecting adjusted EPS between $2.60 and $2.80. This compares with the current analyst consensus of $2.65 per share. Bath & Body Works' stock closed at $17.58, reflecting a 12.19% decline over the past three months and a 44.26% drop over the last 12 months.
Analysts have revised earnings estimates upward in recent months, with 13 positive revisions and one downgrade over the past 90 days. InvestingPro rated the company's financial health as demonstrating "good performance."
